Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $2.30 billion. The enterprise value is $2.20 billion.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CNTA has 134.07 million shares outstanding. The number of shares has increased by 27.54% in one year.
Current Share Class | n/a |
Shares Outstanding | 134.07M |
Shares Change (YoY) | +27.54% |
Shares Change (QoQ) | +0.48% |
Owned by Insiders (%) | 0.83% |
Owned by Institutions (%) | 58.99% |
Float | 85.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 146.93 |
Forward PS | n/a |
PB Ratio | 6.64 |
P/TBV Ratio | 6.76 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 146.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.12, with a Debt / Equity ratio of 0.34.
Current Ratio | 10.12 |
Quick Ratio | 9.81 |
Debt / Equity | 0.34 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -19.12 |
Financial Efficiency
Return on equity (ROE) is -72.92% and return on invested capital (ROIC) is -30.90%.
Return on Equity (ROE) | -72.92% |
Return on Assets (ROA) | -28.96% |
Return on Invested Capital (ROIC) | -30.90% |
Return on Capital Employed (ROCE) | -44.64% |
Revenue Per Employee | $194,805 |
Profits Per Employee | -$2.99M |
Employee Count | 77 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $3.83 million in taxes.
Income Tax | 3.83M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.34% in the last 52 weeks. The beta is 1.48, so CNTA's price volatility has been higher than the market average.
Beta (5Y) | 1.48 |
52-Week Price Change | +55.34% |
50-Day Moving Average | 14.42 |
200-Day Moving Average | 15.19 |
Relative Strength Index (RSI) | 62.14 |
Average Volume (20 Days) | 1,135,520 |
Short Selling Information
Short Interest | 4.36M |
Short Previous Month | 3.67M |
Short % of Shares Out | 3.85% |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.13 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$230.37 million in losses. Loss per share was -$1.79.
Revenue | 15.00M |
Gross Profit | 15.00M |
Operating Income | -206.42M |
Pretax Income | -163.67M |
Net Income | -230.37M |
EBITDA | -206.11M |
EBIT | -206.42M |
Loss Per Share | -$1.79 |
Full Income Statement Balance Sheet
The company has $250.72 million in cash and $117.49 million in debt, giving a net cash position of $133.24 million or $0.99 per share.
Cash & Cash Equivalents | 250.72M |
Total Debt | 117.49M |
Net Cash | 133.24M |
Net Cash Per Share | $0.99 |
Equity (Book Value) | 344.92M |
Book Value Per Share | 2.58 |
Working Capital | 270.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$143.89 million and capital expenditures -$160,000, giving a free cash flow of -$144.05 million.
Operating Cash Flow | -143.89M |
Capital Expenditures | -160,000 |
Free Cash Flow | -144.05M |
FCF Per Share | -$1.07 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,376.10% |
Pretax Margin | -1,510.27% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.54% |
Shareholder Yield | -27.54% |
Earnings Yield | -9.88% |
FCF Yield | -6.18% |
Analyst Forecast
The average price target for CNTA is $28.90, which is 68.61% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.90 |
Price Target Difference | 68.61% |
Analyst Consensus | Strong Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |